Cargando…
A sharp decrease of Th17, CXCR3(+)-Th17, and Th17.1 in peripheral blood is associated with an early anti-IL-17-mediated clinical remission in psoriasis
Psoriasis—an immune-mediated skin disease—implicates in its pathophysiology by circulating pro-inflammatory cell populations, cytokines, and their interactions with the epidermis. The direct effect of approved anti-interleukin- (IL-)17A and anti-IL-17R biologic therapy on immunophenotyping of periph...
Autores principales: | Tsiogkas, Sotirios G, Mavropoulos, Athanasios, Dardiotis, Efthimios, Zafiriou, Efterpi, Bogdanos, Dimitrios P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585551/ https://www.ncbi.nlm.nih.gov/pubmed/35925616 http://dx.doi.org/10.1093/cei/uxac069 |
Ejemplares similares
-
Gallic acid diminishes pro-inflammatory interferon-γ- and interleukin-17-producing sub-populations in vitro in patients with psoriasis
por: Tsiogkas, Sotirios G., et al.
Publicado: (2023) -
Novel Th17 Lymphocyte Populations, Th17.1 and PD1+Th17, are Increased in Takayasu Arteritis, and Both Th17 and Th17.1 Sub-Populations Associate with Active Disease
por: Singh, Kritika, et al.
Publicado: (2022) -
The Role of Flavonoids in Inhibiting Th17 Responses in Inflammatory Arthritis
por: Kelepouri, Dimitra, et al.
Publicado: (2018) -
Depression and Obesity in Patients With Psoriasis and Psoriatic Arthritis: Is IL-17-Mediated Immune Dysregulation the Connecting Link?
por: Zafiriou, Efterpi, et al.
Publicado: (2021) -
Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
por: Sakkas, Lazaros I., et al.
Publicado: (2019)